Penghong Song
Overview
Explore the profile of Penghong Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
963
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia X, Zhu X, Chen S, Qiu Q, Song W, Zhang S, et al.
J Adv Res
. 2025 Feb;
PMID: 39978541
Introduction: Hepatocellular carcinoma (HCC) is an extremely heterogeneous malignancy with a poor prognosis, highlighting the need to target specific vulnerabilities within the tumor during treatment. Objectives: This study employs multi-omics...
2.
Cui D, Shao S, Qu R, Chen X, Jiang S, Wang L, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2404718.
PMID: 39932049
RNA polymerase II-associated protein 2 (RPAP2) plays a critical role in transcriptional regulation. However, little is known about whether and how RPAP2 regulates hepatocellular carcinoma (HCC) cell growth, and how...
3.
Tang H, Dilimulati D, Yang Z, Zhou K, Chen X, Sun R, et al.
EBioMedicine
. 2024 Apr;
103:105099.
PMID: 38604089
Background: Hepatocellular carcinoma (HCC) is a highly prevalent and deadly type of cancer, and although pharmacotherapy remains the cornerstone of treatment, therapeutic outcomes are often unsatisfactory. Pharmacological inhibition of mammalian...
4.
Zhang S, Jia X, Dai H, Zhu X, Song W, Bian S, et al.
Cancer Commun (Lond)
. 2024 Feb;
44(3):384-407.
PMID: 38407942
Background: Liver cancer is a malignancy with high morbidity and mortality rates. Serpin family E member 2 (SERPINE2) has been reported to play a key role in the metastasis of...
5.
Wang N, Zhou K, Liang Z, Sun R, Tang H, Yang Z, et al.
Int Immunopharmacol
. 2023 Nov;
125(Pt B):111172.
PMID: 37951193
Inhibition of mammalian target of rapamycin (mTOR), which is a component of both mTORC1 and mTORC2, leads to clinical benefits for organ transplant recipients. Pathways to inhibit mTOR include strengthening...
6.
Li Z, Dong H, Bian S, Wu H, Song W, Jia X, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686300
Biliary obstruction diseases are often complicated by an impaired intestinal barrier, which aggravates liver injury. Treatment of the intestinal barrier is often neglected. To investigate the mechanism by which intestinal...
7.
Yang Z, Xie H, Wan J, Wang Y, Zhang L, Zhou K, et al.
EBioMedicine
. 2023 May;
92:104594.
PMID: 37167784
Background: Long-term treatment with immunosuppressants is necessary to attenuate allograft rejection following organ transplantation (OT). Consequently, the overall survival of OT recipients with malignancies has been substantially compromised by tumour...
8.
Zhu X, Song G, Zhang S, Chen J, Hu X, Zhu H, et al.
Cancer Res
. 2022 Aug;
82(21):3987-4000.
PMID: 36043912
Significance: ASGR1 downregulation by DNA methylation facilitates liver tumorigenesis by increasing STAT3 phosphorylation.
9.
Bian S, Dong H, Zhao L, Li Z, Chen J, Zhu X, et al.
Adv Sci (Weinh)
. 2022 Aug;
9(29):e2201931.
PMID: 36026578
Pancreatic ductal adenocarcinoma (PDAC), one of the worst prognosis types of tumors, is characterized by dense extracellular matrix, which compresses tumor vessels and forms a physical barrier to inhibit therapeutic...
10.
Chen J, Li Z, Jia X, Song W, Wu H, Zhu H, et al.
Oncogene
. 2022 Apr;
41(22):3118-3130.
PMID: 35477750
Targeting cytokinesis can suppress tumor growth by blocking cell division and promoting apoptosis. We aimed to characterize key cytokinesis regulator in hepatocellular carcinoma (HCC) progression, providing insights into identifying promising...